1. Dahlin DC. Bone Tumors: General Aspects and Data on 6,221 Cases 1978;3rd ed. Springfield, IL: Charles C Thomas.
2. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA cancer J Clin 2002;52:23-47.
3. Frassica FJ, Gitelis S, Sim FH. Metastatic bone disease: General principles, pathophysiology, evaluation, and biopsy. Instr Course Lect 1992;41:293-300.
4. Rougraff BT, Kneisl JS, Simon MA. Skeletal metastases of unknown origin: A prospective study of a diagnotic strategy. J bone Joint Surg Am 1993;75:1276-1281.
5. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-573.
6. In: Ewing J, editor. Metastasis, in Neoplastic Diseases: A Treatise on Tumor 1928;3rd ed. Philadelphia: WB Saunders. 77-89.
7. Canale ST. Campbell's operative orthopaedics 2003;10th ed. Mosby: 848.
8. Clohisy DR, Palkert D, Ramnaraine ML, Pekurovsky I, Oursler MJ. Human breast cancer induces osteoclast activation and increases the number of osteoclast at sites of tumor osteolysis. J Orthop Res 1996;14:396-402.
9. Beals RK, Lawton GD, Snell WE. Prophylactic internal fixation of the femur in metastatic breast cancer. Cancer 1971;28:1350-1354.
10. Mirels H. Metastatic disease in long bones: A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop 1989;249:256-264.
11. Katzer A, Meenen NM, Grabbe F, Reuger JM. Surgery of skeletal metastases. Arch Orthop Trauma Surg 2002;122:251-258.
12. Redmond BJ, Biermann JS, Blasier RB. Interlocking intramedullary nailing of pathological fractures of the shaft of the humerus. J Bone Joint Surg Am 1996;78:891-896.
13. Damron TA, Sim FH, Shives TC, An KN, Rock MG, Pritchard DJ. Intercalary spacers in the treatment of segmentally destructive diaphyseal humeral lesions in disseminated malignancies. Clin Othop 1996;324:233-243.
14. Dijkstra S, Stapert J, Boxma H, Wiggers T. Treatment of pathological fractures of the humeral shaft due to bone metastases: A comparison of intramedullay locking nail and plate osteosynthesis with adjunctive bone cement. Eur J Surg Oncol 1996;22:621-626.
15. Harrington KD. The management of acetabular insufficiency secondary to metastatic malignant disease. J Bone Joint Surg Am 1981;63:653-664.
16. Marco RA, Sheth DS, Boland PJ, et al. Functional and oncological outcome of acetabular reconstruction for the treatment of metastatic disease. J Bone Joint Surg Am 2000;82:642-651.
17. Vena VE, Hsu J, Rosier RN, O'Keefe RJ. Pelvic reconstruction for severe periacetabular metastatic disease. Clin Orthop 1999;362:171-180.
18. Yazawa Y, Frassica FJ, Chao EY, Pritchard DJ, Sim FH, Shives TC. Metastatic bone disease: A study of the surgical treatment of 166 pathologic humeral and femoral fractures. Clin Orthop 1990;251:213-219.
19. Lane JM, Sculco TP, Zolan S. Treatment of pathological fractures of the hip by endoprosthetic replacement. J Bone Joint Surg Am 1980;62:954-959.
20. Papagelopoulos PJ, Galanis EC, Greipp PR, Sim FH. Prosthetic hip replacement for pathologic or impending pathologic fractures in myeloma. Clin Orthop 1997;341:192-205.
21. Behr JT, Dobozi WR, Badrinath K. The treatment of pathologic and impending pathologic fractures of the proximal femur in the elderly. Clin Orthop 1985;198:173-178.
22. Ward WG, Spang J, Howe D, Gordan S. Femoral recon nails for metastatic disease: Indications, technique, and results. Am J Orthop 2000;29:S9. 34-42.
23. Weikert DR, Schwartz HS. Intramedullary nailing for impending pathological subtrochanteric fractures. J Bone Joint Surg Br 1991;73:668-670.
24. Favorito PJ, McGrath BE. Impending or completed pathologic femur fracruters treated with intramedullary hip screws. Orthopedics 2001;24:359-363.
25. Sim FH, Chao EY. Hip salvage by proximal femoral replacement. J Bone Joint Surg Am 1981;63:1228-1239.
26. Healey JH, Lane JM. Treatment of pathologic fractures of the distal femur with the Zickel supracondylar nail. Clin Orthop 1990;250:216-220.
27. De Geeter K, Reynders P, Samson I, Broos PL. Metastatic fractures of the tibia. Acta Orthop Belg 2001;67:54-59.
28. Hattrup SJ, Amadio PC, Sim FH, Lombardi RM. Metastatic tumors of the foot and ankle. Foot Ankle 1988;8:243-247.
29. Boland PJ, Lane JM, Sundaresan N. Metastatic disease of the spine. Clin Orthop 1982;169:95-102.
30. Suen KC, Lau LL, Yermakov V. Cancer and old age. An autopsy study of 3,535 patients over 65 years old. Cancer 1974;33:1164-1168.
31. Galasko CS, Sylvester BS. Back pain in patients treated for malignant tumours. Clin Oncol 1978;4:273-283.
32. Gilbert RW, Kim JH, Posner JB. Epidural spinal cord compression from metastatic tumor: Diagnosis and treatment. Ann Neurol 1978;3:40-51.
33. Weill A, Chiras J, Simon JM, Rose M, Sola-Martinez T, Enkaoua E. Spinal metastases: Indications for and results of percutaneous injection of acrylic surgical cement. Radiology 1996;199:241-247.
34. Harrington KD. Metastatic disease of the spine. J Bone Joint Surg Am 1986;68:1110-1115.
35. Arcangeli G, Micheli A, Arcangeli F, et al. The responsiveness of bone metastases to radiotherapy: The effect of site, histology and radiation dose on pain relief. Radiolther Oncol 1989;14:95-101.
36. Coleman RE. Management of bone metastases. Oncologist 2000;5:463-470.
37. Crawford ED, Eisenberger MA, McLeod DG, et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 1989;321:419-424.
38. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine 2000;01. 26:298-306.